// App-Quantinova.ai

IMMU-27 : LONG TERM STABILIZATION OF RECURRENT HIGH-GRADE GLIOMA WITH PD-1 INHIBITOR PEMBROLIZUMAB IN TWO CASES

Researchers

Presenter

  • Matthew Moldenhauer

Principal Investigators

  • Steven Du

  • Dan Fu

  • Joon Myung

  • Daniela Bota

  • Xiao-Tang Kong

Medical Centers

  • University of Southern California, Los Angeles, CA, USA

  • University of California, Irvine, Irvine, CA, USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Anaplastic oligodendroglial tumors

  • High-Grade Gliomas

  • Glioblastoma

  • Brain cancer

  • Gliomas

Biomarkers

  • O-6-methylguanine DNA methyltransferase

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Hematocrit

Drug/Treatment

  • Pembrolizumab

  • Temozolomide

  • Bevacizumab

  • Carboplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved